Sma News & Perspectives

First Patient Treated in The Phase 2/3 Trial, Assessing Higher Doses of Spinraza

Informações:

Sinopsis

Forums Director Kevin Schaefer writes about a new at-home exercise routine he’s developed, using his electric ceiling lift. SMA News Today’s multimedia associate, Price Wooldridge, discusses the first patient treated in the Phase 2/3 trial, assessing higher doses of Spinraza. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/